home / stock / hbp / hbp news


HBP News and Press, Huttig Building Products Inc. From 07/24/19

Stock Information

Company Name: Huttig Building Products Inc.
Stock Symbol: HBP
Market: NASDAQ
Website: huttig.com

Menu

HBP HBP Quote HBP Short HBP News HBP Articles HBP Message Board
Get HBP Alerts

News, Short Squeeze, Breakout and More Instantly...

HBP - Helix Biopharma Corp. to Present at RHK Capital Conference in New York

RICHMOND HILL, Ontario, July 24, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces that it will be presenti...

HBP - Huttig Building Products, Inc. Schedules Second Quarter 2019 Earnings Call

ST. LOUIS, Mo., July 16, 2019 (GLOBE NEWSWIRE) -- Huttig Building Products (Nasdaq: HBP), one of the nation's largest wholesale distributors of millwork and specialty building products used principally in new residential construction and home improvement, plans to release its second quarter...

HBP - Helix BioPharma Corp. Submits L-DOS47 IND Application With U.S. FDA for Pancreatic Cancer

RICHMOND HILL, Ontario, July 09, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the submission of ...

HBP - Helix BioPharma Corp. Announces Fiscal Third Quarter 2019 Results

RICHMOND HILL, Ontario, June 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces its financi...

HBP - Helix BioPharma Corp. Initiates OTCQB Application and Hires U.S. Investor Relations Firm

RICHMOND HILL, Ontario, May 30, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced that it has commenced the...

HBP - Helix BioPharma Corp. Closes Private Placement

RICHMOND HILL, Ontario, May 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it h...

HBP - Huttig Building Products, Inc. Announces Amendment to Existing Rights Plan to Protect Net Operating Loss Carryforwards

ST. LOUIS, May 06, 2019 (GLOBE NEWSWIRE) -- Huttig Building Products, Inc. (“Huttig” or the “Company”) (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, announced today that its Board of Directors has approved an ame...

HBP - Huttig Building Products, Inc. (HBP) CEO Jon Vrabely on Q1 2019 Results - Earnings Call Transcript

Huttig Building Products, Inc. (HBP) Q1 2019 Earnings Conference Call April 30, 2019 11:00 AM ET Company Participants Jon Vrabely - President, Chief Executive Officer and Director Philip Keipp - Chief Financial Officer and Executive Vice President Bob Furio - Executive Vice Presi...

HBP - L-DOS47 Phase II Randomized Study Advances to Second Cohort

RICHMOND HILL, Ontario, May 01, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, has announced that the Trial Steeri...

HBP - Huttig Building Products down 5% post Q1 results

Huttig Building Products ( HBP -5.4% ) reported net sales of $197.4M a slight decrease of 0.3% Y/Y, due to lower market activity and severe weather. More news on: Huttig Building Products, Inc., Earnings news and commentary, Stocks on the move, , Read more ...

Previous 10 Next 10